For Love And Money: 3 Growth Stocks From Casey's Alex Daley
Jun 14 2013 After Close Friday Seeking Alpha By: Life Sciences Report
Casey Alex Daley Funds Explains ,MannKind's inhalable insulin product, Afrezza [human insulin of recombinant DNA [rDNA]] is an ultra fast-acting insulin that peaks 12-14 minutes from the time the patient inhales, versus an hour and a half for
injectable insulin. Afrezza is an excellent tool for managing blood sugar.
thanks for pointing that out.